EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, DSGN: Design Therapeutics Inc

10 Dec 25 15:59
LAST:

9.420

CHANGE:
 0.15		OPEN:
9.200		HIGH:
9.533		ASK:
0.000		VOLUME:
97.7K
CHG(%):
1.62		PREV:
9.270		LOW:
9.000		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Dec 259.2009.5339.0009.420202.5K
09 Dec 259.81010.0699.1209.270221.6K
08 Dec 259.62010.1759.3809.860224.0K
05 Dec 259.89010.3069.6909.770296.5K
04 Dec 259.68010.0209.3309.820320.1K
03 Dec 259.55010.0009.0509.770957.0K
02 Dec 259.0009.2108.5808.940393.8K
01 Dec 259.2609.3508.7508.950143.0K
28 Nov 259.4009.5909.0659.390124.2K
26 Nov 259.5009.8509.3409.370416.4K

PROFILE

Name:Design Therapeutics Inc
About:Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
Sector:Healthcare
Industry:Biotechnology
Address:6005 Hidden Valley Road, Carlsbad, CA, United States, 92011
Website:https://www.designtx.com
CUSIP:25056L103
CIK:0001807120
ISIN:US25056L1035
FIGI:BBG00SNC49V8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-7.44 
Forward P/E:-5.54 
PEG Ratio:-0.12 
Price to Sales:22,642.01 
Price to Book:1.79 
Return on Assets:-0.19 
Return on Equity:-0.27 
EPS Ratio:-1.12 
Revenue:33.0K 
Shares:56.95M 
Market Cap:536.45M 

TECHNICAL INDICATORS

MA5:9.632.2%
MA10:9.460.4%
MA20:8.668.8%
MA50:7.3727.9%
MA100:6.3448.5%
MA200:5.1682.5%
STO9:35.14
STO14:63.63
RSI14:73.96 
WPR14:-22.11
MTM14:1.55
ROC14:0.20 
ATR:0.77 
Week High:10.319.4%
Week Low:9.004.7%
Month High:10.319.4%
Month Low:6.6882.5%
Year High:10.319.4%
Year Low:2.60262.3%